1. Home/
  2. Compounds/
  3. navitoclax:birinapant (1:1 mol/mol)

navitoclax:birinapant (1:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2navitoclax:birinapant (1:1 mol/mol)
PharmacoGx navitoclax:birinapant (1:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to navitoclax:birinapant (1:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA NCKAP1L CTRPv2 pan-cancer AAC 0.28 1e-07
mRNA ZNF606 CTRPv2 pan-cancer AAC 0.25 2e-11
mRNA GMFG CTRPv2 pan-cancer AAC 0.25 6e-07
mRNA VPS4B CTRPv2 pan-cancer AAC 0.23 5e-11
mRNA YPEL1 CTRPv2 pan-cancer AAC 0.22 4e-09
mRNA CPXM1 CTRPv2 pan-cancer AAC 0.22 9e-09
mRNA SPN CTRPv2 pan-cancer AAC 0.22 6e-06
mRNA ZIK1 CTRPv2 pan-cancer AAC 0.22 8e-09
mRNA WAS CTRPv2 pan-cancer AAC 0.22 0.001
mRNA ZNF71 CTRPv2 pan-cancer AAC 0.22 7e-08
Download CSV